PURA Pop Potential From Under $0.03 To $0.15 After Gap Open To $0.04
March 03 2020 - 2:38PM
InvestorsHub NewsWire
PURA Pop Potential From Under $0.03
To $0.15 After Gap Open To $0.04
March 3, 2020 -- InvestorsHub NewsWire --
via NextBigTicker
Puration, Inc. (USOTC:PURA)
gapped open today trading at $0.04 after closing under $0.03
yesterday. The PURA PPS has been trading around the $0.03
range now for days. The OTC Short Report indicates high short selling
volume. Short sellers have been trying to profit in the
cannabis market now for about the last year and doubled down of
late in the Coronavirus market. PURA operational performance
continues to be strong and has recently added a rollup
campaign. PURA has been resilient against short
sellers. The gap open to $0.04 today is an indication that
short sellers efforts may be weakening. PURA has a $0.15 52-week
high. PURA has a history of big periodic runs. The
company has just started a rollup campaign of CBD infused beverage,
edible and topical operations backed by a recent $5 million
investment.
Once the coronavirus market reaction passes,
PURA stands to enjoy a potential PPS
spike.
Analyst Speculative Buy and $0.35 PPS
Target
PURA on Wednesday last
week announced a next iteration of an ongoing CBD consumer survey
conducted by Goldman Research on behalf of PURA to gauge and refine
the company’s ongoing approach to the CBD consumer
market.
The Goldman CBD consumer survey included a PURA
speculative BUY recommendation and at $0.35 target PPS. PURA
closed yesterday at $0.29. Realizing the target PPS could
deliver a 1000% ROI. |
The full CBD consumer
survey update can be viewed at GOLDMAN CBD
SURVEY.
Data443 Risk Mitigation (ATDS),
Hemp (HEMP)
and Medical Marijuana (MJNA)
are otherl stocks that warrant some interest at this
time.
Disclaimer:
NextBigTicker.com (NBT)is a third party publisher
and news dissemination service provider. NBT is NOT affiliated
in any manner with any company mentioned herein. NBT is news
dissemination solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. NBT's
market updates, news alerts and corporate profiles are NOT a
solicitation or recommendation to buy, sell or hold securities. The
material in this release is intended to be strictly informational
and is NEVER to be construed or interpreted as research material.
All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial
professional before considering any level of investing in
stocks. All material included herein is republished content
and details which were previously disseminated by the companies
mentioned in this release or opinion of the writer. NBT is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. NBT has not been
compensated for this release and HOLDS NO SHARES OF ANY
COMPANY NAMED IN THIS RELEASE.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur.
Source: www.nextbigticker.com
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Nov 2023 to Nov 2024